Ubs Asset Management Americas Inc Pliant Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 154,906 shares of PLRX stock, worth $209,123. This represents 0.0% of its overall portfolio holdings.
Number of Shares
154,906
Previous 139,574
10.98%
Holding current value
$209,123
Previous $1.84 Million
88.63%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PLRX
# of Institutions
154Shares Held
62.2MCall Options Held
279KPut Options Held
7.1K-
Tang Capital Management LLC San Diego, CA6MShares$8.1 Million0.53% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.4MShares$7.29 Million0.25% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$6.71 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.33MShares$4.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.05MShares$4.12 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $65.7M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...